Penobscot Investment Management Company Inc. recently decreased its Chevron Corporation holdings by 5.3%. The firm sold 2,160 shares, leaving it with a total of 38,591 shares valued at $5,526,000.
Quent Capital LLC has reduced its stake in Sprouts Farmers Market by 8%, selling 291 shares in the second quarter. Despite the cut, the firm retains 3,334 shares valued at $549,000.
Penobscot Investment Management Company Inc. has reduced its position in Pfizer Inc. by 9.5% in the second quarter. According to the latest SEC filing, the institutional investor sold 9,075 Pfizer shares, leaving the firm with 86,226 shares of the prominent biopharmaceutical company.
Signaturefd LLC recently sold 1,694 shares of CNH Industrial, reducing its stake by 14%. According to SEC filings, the firm now holds 10,435 shares, worth $135,000 as of the latest quarter. This transaction highlights a noteworthy portfolio adjustment for the financial firm.
Trivium Point Advisory LLC has reduced its stake in Zoetis Inc. by 8.1% during the second quarter, selling 1,318 shares. Filings with the Securities & Exchange Commission indicate the firm now holds 14,997 shares of the company’s stock.
True North Advisors LLC recently reduced its holdings in semiconductor giant Lam Research Corporation (NASDAQ:LRCX), selling 3,522 shares during the second quarter. The move, which represents a 10.2% decrease in the firm’s stake, was disclosed in a filing with the Securities and Exchange Commission.
Magnus Financial Group LLC reduced its stake in the iShares MSCI USA Momentum Factor ETF by 5.7%, according to the latest SEC filings. The firm sold 344 shares during the second quarter, leaving it with 5,738 shares valued at $1.38 million.
CHICAGO TRUST Co NA has cut its stake in Lowe’s Companies, Inc. by 40.2% during the second quarter, selling 1,410 shares. The firm currently holds 2,101 shares, according to a filing with the Securities & Exchange Commission.
CX Institutional reduced its holdings in Tractor Supply Company by 8.1% during the second quarter, according to an SEC filing. The firm sold 338 shares, leaving it with 3,845.
Baker Tilly Wealth Management LLC recently cut its stake in AbbVie Inc. by 3.5%, selling 169 shares in the second quarter. This downward adjustment, disclosed in the firm’s Form 13F filing, leaves the institutional investor with 4,602 shares.
